PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 105 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,000 | 0.0% | 3,015 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +33.3% | 3,015 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -33.3% | 3,015 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +28.6% | 3,015 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 3,015 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +10.0% | 3,015 | 0.0% | 0.00% | – |
| Q3 2019 | $10,000 | -28.6% | 3,015 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $14,000 | +40.0% | 3,015 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | +25.0% | 3,015 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -52.9% | 3,015 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $17,000 | +13.3% | 3,015 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $15,000 | -28.6% | 3,015 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | -8.7% | 3,015 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $23,000 | +43.8% | 3,015 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $16,000 | +6.7% | 3,015 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | – | 3,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |